BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20702746)

  • 1. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
    Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
    J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.
    Ibiebele TI; Hughes MC; Nagle CM; Bain CJ; Whiteman DC; Webb PM;
    Int J Cancer; 2013 Jul; 133(1):214-24. PubMed ID: 23292980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Sharp L; Carsin AE; Cantwell MM; Anderson LA; Murray LJ;
    J Nutr; 2013 Dec; 143(12):1966-73. PubMed ID: 24132576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus.
    Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP; Buffler P; Corley DA
    Am J Gastroenterol; 2008 Jul; 103(7):1614-23; quiz 1624. PubMed ID: 18494834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population.
    Ibiebele TI; Hughes MC; Pandeya N; Zhao Z; Montgomery G; Hayward N; Green AC; Whiteman DC; Webb PM; ;
    J Nutr; 2011 Feb; 141(2):274-83. PubMed ID: 21178085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma.
    O'Doherty MG; Cantwell MM; Murray LJ; Anderson LA; Abnet CC;
    Int J Cancer; 2011 Sep; 129(6):1493-502. PubMed ID: 21455992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the vitamins A, C and E in the prevention of gastroesophageal reflux disease, Barrett's oesophagus and oesophageal adenocarcinoma.
    Lukić M; Segec A; Segec I; Pinotić L; Pinotić K; Atalić B; Solić K; Vcev A
    Coll Antropol; 2012 Sep; 36(3):867-72. PubMed ID: 23213946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
    Lam S; Hart AR
    Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
    Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.
    Realdon S; Antonello A; Arcidiacono D; Dassie E; Cavallin F; Fassan M; Nardi MT; Alberti A; Rugge M; Battaglia G
    Eur J Nutr; 2016 Jun; 55(4):1563-71. PubMed ID: 26155779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants and cancers of the esophagus and gastric cardia.
    Terry P; Lagergren J; Ye W; Nyrén O; Wolk A
    Int J Cancer; 2000 Sep; 87(5):750-4. PubMed ID: 10925371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary antioxidant intake and the risk of developing Barrett's oesophagus and oesophageal adenocarcinoma.
    Kang JH; Luben R; Alexandre L; Hart AR
    Br J Cancer; 2018 Jun; 118(12):1658-1661. PubMed ID: 29780162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's esophagus and esophageal adenocarcinoma in adults: long-term GERD or something else?
    Pondugula K; Wani S; Sharma P
    Curr Gastroenterol Rep; 2007 Dec; 9(6):468-74. PubMed ID: 18377797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
    Dong LM; Kristal AR; Peters U; Schenk JM; Sanchez CA; Rabinovitch PS; Blount PL; Odze RD; Ayub K; Reid BJ; Vaughan TL
    Nutr Cancer; 2008; 60(1):39-48. PubMed ID: 18444134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.
    Wang GQ; Dawsey SM; Li JY; Taylor PR; Li B; Blot WJ; Weinstein WM; Liu FS; Lewin KJ; Wang H
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):161-6. PubMed ID: 8049638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.